Atlas Trials

Intensive Monitoring Scheme of Lidocaine Cataplasms

Clinical trial NCT05645302 · UNKNOWN

Trial details

NCT number
NCT05645302
Sponsor
Qianfoshan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Adverse Reaction to Drug
Start date
2022-04-06
Primary completion
2022-10-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.